Closed Solicitation · DEPARTMENT OF VETERANS AFFAIRS

    AJ13--PHARMARCOKINETICS FOR EXPERIMENTAL RHEUMATOID ARTHRITIS TREATMENT

    DEPARTMENT OF VETERANS AFFAIRS
    Sol. 36C24526Q0669PresolicitationLINTHICUM, MD
    Closed
    STATUS
    Closed
    closed Jul 31, 2026
    POSTED
    Jul 16, 2026
    Publication date
    NAICS CODE
    112990
    Primary industry classification
    PSC CODE
    AJ13
    Product & service classification

    AI Summary

    The Department of Veterans Affairs seeks a contractor for preclinical toxicology and pharmacokinetic studies to support an experimental rheumatoid arthritis treatment. The work includes GLP compliant toxicity studies and pharmacokinetic assessments in adult rats, with a performance period from September 2026 to September 2027. This notice is for informational purposes only, and a formal solicitation will follow.

    Contract details

    Solicitation No.
    36C24526Q0669
    Notice Type
    Presolicitation
    Posted Date
    July 16, 2026
    Response Deadline
    July 31, 2026
    NAICS Code
    112990AI guide
    PSC / Class Code
    AJ13
    Primary Contact
    Robert O'Keefe Jr.
    State
    MD
    ZIP Code
    21090
    AI Product/Service
    service

    Description

    PRE SOLICITATION NOTICE Department of Veterans Affairs Network Contracting Office (NCO) 05 Title: A Joint Targeted Drug Delivery Approach for Arthritis Therapy Toxicity and Pharmacokinetics The Department of Veterans Affairs (VA), Network Contracting Office (NCO) 05, intends to issue a solicitation for preclinical toxicology and pharmacokinetic (PK) studies to support advancement of an experimental joint targeted liposomal delivery system for Rheumatoid Arthritis therapy. This requirement involves GLP compliant toxicity studies and GLP or non GLP PK studies in adult rats. The forthcoming solicitation will seek a contractor capable of performing: GLP single dose IV toxicity studies including clinical observations, weight/food intake monitoring, blood chemistry assessments, necropsy, and histopathology. GLP or non GLP pharmacokinetic studies including IV dosing, timed blood collection, plasma processing and storage, LC MS/MS analysis of dexamethasone and 6 hydroxydexamethasone, and calculation of PK parameters. A comprehensive final written report covering toxicity results, PK data, and analytical findings. Place of performance will be the contractor s laboratory. The anticipated period of performance is one year, approximately September 15, 2026 through September 14, 2027. This notice is issued solely for informational purposes. A formal solicitation and the Government s acquisition strategy will be issued after completion of market research. This notice does not constitute a solicitation and does not commit the Government to award a contract. Point of Contact: Robert O Keefe Jr., Contract Specialist Email: robert.okeefejr@va.gov

    Key dates

    1. July 16, 2026Posted Date
    2. July 31, 2026Proposals / Responses Due

    AI search tags

    Frequently asked questions

    AJ13--PHARMARCOKINETICS FOR EXPERIMENTAL RHEUMATOID ARTHRITIS TREATMENT is a federal acquisition solicitation issued by DEPARTMENT OF VETERANS AFFAIRS. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.

    SamSearch Platform

    Stop searching. Start winning.

    AI-powered intelligence for the right opportunities, the right leads, and the right time.